We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals

134 hedge funds and large institutions have $478M invested in Amphastar Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

3.57% more ownership

Funds ownership: 47.43%51% (+3.6%)

1% more capital invested

Capital invested by funds: $471M → $478M (+$6.53M)

1% more funds holding

Funds holding: 133134 (+1)

6% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 50

96% less call options, than puts

Call options by funds: $19K | Put options by funds: $496K

Holders
134
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
47
Reduced
50
Closed
15
Calls
$19K
Puts
$496K
Net Calls
-$477K
Net Calls Change
+$19K
Name Holding Trade Value Shares
Change
Change in
Stake
MWNA
101
Marshall Wace North America
New York
$222K +$233K +11,191 New
ACI
102
AMP Capital Investors
Australia
$212K +$219K +10,500 New
MERSOM
103
Municipal Employees' Retirement System of Michigan
Michigan
$205K +$833 +40 +0.4%
TRSOTSOK
104
Teachers Retirement System of the State of Kentucky
Kentucky
$139K
QT
105
Quantbot Technologies
New York
$89K -$27.1K -1,300 -22%
LIA
106
LS Investment Advisors
Michigan
$73K
AIP
107
Ameritas Investment Partners
Nebraska
$61K
PCM
108
Prelude Capital Management
New York
$48K -$72.9K -3,500 -59%
Zurich Cantonal Bank
109
Zurich Cantonal Bank
Switzerland
$48K
PNC Financial Services Group
110
PNC Financial Services Group
Pennsylvania
$48K +$2K +96 +4%
SDIC
111
South Dakota Investment Council
South Dakota
$47K +$49.2K +2,360 New
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$34K -$729 -35 -2%
QT
113
Quantamental Technologies
New York
$26K -$14.5K -696 -35%
MOACM
114
Mutual of America Capital Management
New York
$25K +$396 +19 +2%
Lazard Asset Management
115
Lazard Asset Management
New York
$22K +$23.3K +1,117 New
WAP
116
Wealthcare Advisory Partners
Pennsylvania
$21K +$22.1K +1,060 New
AG
117
Advisor Group
Arizona
$16K
MAM
118
Meeder Asset Management
Ohio
$15K -$229K -11,008 -94%
Simplex Trading
119
Simplex Trading
Illinois
$10K -$6.44K -309 -36%
SWA
120
Sutton Wealth Advisors
Florida
$9.68K
Daiwa Securities Group
121
Daiwa Securities Group
Japan
$6K
CHC
122
City Holding Co
West Virginia
$4K -$4.17K -200 -50%
TWA
123
TCI Wealth Advisors
Arizona
$4K -$1.65K -79 -29%
LTFS
124
Ladenburg Thalmann Financial Services
Florida
$4K
MIM
125
Macroview Investment Management
Maryland
$3K +$3K +144 New

AMPH Hedge Fund Activity: Q3 2019 in Review

134 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2019, worth a combined $478M — up 1.4% from $471M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 47 added to existing stakes and 50 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $12.2M. The largest seller was Nuveen, cutting an estimated $5.65M.

  • 134 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2019, up from 133 in Q2 2019.
  • Funds reported $478M of Amphastar Pharmaceuticals stock for Q3 2019, up 1.4% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2019 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2019 was VOYA Investment Management, an estimated $12.2M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2019 was Nuveen, an estimated $5.65M sold.

Based on aggregated 13F filings for Q3 2019.